临床路径在控制乳腺癌手术费用和住院天数分析  

Clinical pathway in control of operation cost and hospital stay time of breast cancer patients

作　　者：贺密会[1] 

机构地区：[1]解放军总医院医学保障部,北京100853

出　　处：《军医进修学院学报》2012年第2期191-192,共2页Academic Journal of Pla Postgraduate Medical School

摘　　要：目的探讨临床路径在控制医疗费用和住院天数方面的价值。方法将乳腺癌患者分为临床路径组(35例)和对照组(38例)。对比两组患者的总住院日、术前住院天数、术后住院天数、住院总费用、药品费、院内感染情况。结果临床路径组的总住院天数和术后住院天数较对照组显著缩短,总住院费用和药品费用也明显降低,患者的年龄、术前住院天数及院内感染情况两组间无统计学差异。结论临床路径能有效降低医疗费用,缩短平均住院天数、规范诊疗行为,为合理收费提供很好的模式。Objective To study the clinical pathway（CP） in control of hospital stay time and medical cost of breast cancer patients. Methods Seventy-three breast cancer patients were divided into CP group（n=35） and control group（n=38）. Total hospital stay time, preoperative hospital stay time, postoperative hospital stay time, total hospitalization cost, drug cost and hospital infection were compared between the two groups. Results The total hospital stay time and postoperative hospital stay time were significantly shorter, and the total hospitalization cost and drug cost were significantly less in CP group than ki ~0tlttol group, No significant difference was found in age, preoperative hospital stay time and hospital infection between the two groups. Conduslon CP can significantly reduce the medical cost, shorten the

关 键 词：临床路径 乳腺癌 医业管理 

分 类 号：R197.3[医药卫生—卫生事业管理]